Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1992-3-24
|
pubmed:abstractText |
The systemic administration of neurotensin (NT) dose-dependently increased plasma adrenocorticotropin (ACTH) concentration in rats, and this effect was annulled by (alpha-helical)-CRH9-41, an antagonist of corticotropin-releasing hormone (CRH). The systemic administration of [D-Trp11]-neurotensin (NT-A), a specific NT antagonist, dose-dependently reduced the basal level of circulating ACTH, and this effect was blunted by NT injection. The ACTH inhibitory action of NT-A was completely overcome by the administration of CRH. Taken together, our findings suggest that NT plays a physiologic role in rats, as ACTH secretagogue, and that the mechanism underlying this action of NT involves the stimulation of CRH release.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-43
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1311050-Adrenocorticotropic Hormone,
pubmed-meshheading:1311050-Animals,
pubmed-meshheading:1311050-Corticotropin-Releasing Hormone,
pubmed-meshheading:1311050-Dose-Response Relationship, Drug,
pubmed-meshheading:1311050-Male,
pubmed-meshheading:1311050-Neurotensin,
pubmed-meshheading:1311050-Rats,
pubmed-meshheading:1311050-Rats, Inbred Strains
|
pubmed:year |
1992
|
pubmed:articleTitle |
Neurotensin enhances plasma adrenocorticotropin concentration by stimulating corticotropin-releasing hormone secretion.
|
pubmed:affiliation |
Department of Anatomy, University of Padua, Italy.
|
pubmed:publicationType |
Journal Article
|